Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells

Laryngoscope

Volumn 112, Issue 4, 2002, Pages 645-650

  Krishna, Srinivasan ^a,c   Brown, Neil ^a   Faller, Douglas V ^b   Spanjaard, Remco A ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular differentiation; Head and neck squamous cell carcinoma; Histone deacetylase; Involucrin; Short chain fatty acids

Indexed keywords

2,2 DIMETHYLBUTYRATE; ALPHA METHYL HYDROCINNAMIC ACID; ARGININE BUTYRATE; BUTYRIC ACID DERIVATIVE; HISTONE DEACETYLASE; INVOLUCRIN; KS 11; SHORT CHAIN FATTY ACID; ST 20; ST 7; THIOCTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PREVENTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE CULTURE;

EID: 0036217547     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200204000-00010     Document Type: Article

References (46)

1. Cancer statistics
2. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy
3. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early stage disease
4. Synchronous and metachronous head neck carcinomas
5. Field cancerization in the aerodigestive tract: Its etiology, manifestation and significance
6. Field cancerization in the oral stratified squamous epithelium
7. 13-Cis-retinoic acid in the treatment of oral leukoplakia
8. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck
9. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
10. Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma
11. Short chain fatty acids in human large intestine, portal, hepatic and venous blood
12. Role of short chain fatty acids in the prevention of colorectal cancer
13. Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate
14. Effects of sodium butyrate, a new pharmacological agent, on cells in culture
15. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cell lines
16. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors
17. Arginine butyrate down regulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells
18. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts
19. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines
20. Sodium butyrate induces apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cells
21. Sodium butyrate induces differentiation in breast cancer cell lines expressing the estrogen receptor
22. Effects of arginine butyrate and tributyrylxylitol on cultures human sarcoma cells
23. Histone deacetylase inhibitors as potential anti-skin cancer agents
24. Modulation of Galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate
25. Effects of sodium butyrate on growth, differentiation and apoptosis in head and neck squamous carcinoma cell lines
26. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease
27. A short-term trial of butyrate to stimulate fetal-globin gene statement in the β-globin disorders
28. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma
29. Abrogation of Il-3 requirements and stimulation of hematopoietic cell proliferation in vitro and in vivo by carboxylic acids
30. Erythroid progenitor proliferation is stimulate by phenoxyacetic and phenylalkyl acids
31. Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation
32. Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene statement and hematopoiesis
33. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid: A 3-week multicentre randomized controlled trial (ALADIN Study)
34. Combined effect of lipoic acid and doxorubicin in murine leukemia
35. Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation and inhibition of proliferation of melanoma cells
36. Involucrin structure and role in envelope assembly
37. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
38. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
39. Butyrate as a differentiating agent: Pharmacokinetics, analogues and current status
40. Establishment of order in the flow of genetic information in a cell is not a physiological state function
41. Alpha lipoic acid as a biological antioxidant
42. Alpha lipoic acid: A metabolic antioxidant and potential redox modulator of transcription
43. Ascorbic acid and 6-deoxy-6dechloro-ascorbic acid: Potential anti cancer drugs
44. Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells
45. Immunomodulatory effects of arginine butyrate
46. Phase I trial of interleukin-2 and high dose arginine butyrate in metastatic colon cancer